Quick Answer
INTEGRATED BIOPHARMA INC reported Diluted EPS of $0.03 per share for fiscal year 2025.
INTEGRATED BIOPHARMA INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.03 | — |
| 2024 | $0.00 | — |
| 2023 | $0.00 | -100.0% |
| 2022 | $0.12 | -52.0% |
| 2021 | $0.25 | +92.3% |
| 2020 | $0.13 | +116.7% |
| 2019 | $0.06 | +200.0% |
| 2018 | $0.02 | -80.0% |
| 2017 | $0.10 | +100.0% |
| 2016 | $0.05 | +150.0% |
| 2015 | $0.02 | +100.0% |
| 2014 | $0.01 | — |
| 2013 | $0.00 | +100.0% |
| 2012 | -$0.13 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$0.03 | -400.0% | — |
| September 30, 2025 | $0.00 | -100.0% | -100.0% |
| March 31, 2025 | $0.02 | +100.0% | +100.0% |
| December 31, 2024 | $0.01 | +200.0% | +0.0% |
| September 30, 2024 | $0.01 | — | +0.0% |
| March 31, 2024 | $0.01 | — | +200.0% |
| December 31, 2023 | -$0.01 | -133.3% | — |
| September 30, 2023 | $0.00 | — | — |
- Over the 2012–2025 period, INTEGRATED BIOPHARMA INC’s diluted eps has grown by 123.1% (from $0.13 per share (loss) to $0.03 per share).
- The most recent figure is from INTEGRATED BIOPHARMA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: